To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Synthekine picks up $82m Series A
Menlo Park, California-based Synthekine Inc., an engineered cytokine therapeutics company, has raised $82 million in Series A financing.
